IP Management and IP Strategy


IP Management and IP Strategy

13:45 - 14:30

“Selling” Company IP to Senior Management and Integrating IP within the Company  

Einav Zilber, Director,Global Law Department, Intellectual Property Counsel for Applied Materials Israel and Applied Materials India

Gerson Panitch, Finnegan 

Moderator: Gideon Rosenberg, Deputy General Counsel & Vice President of Legal Affairs, Mellanox Technologies

Bridging the Gap: Company Expectations vs. IP Realities

The many options of dividing labor between IP Managers, outsourced counsel and company personnel.


Ido Warshavski Vice President, General Counsel & Corporate Secretary Lumenis

Yoav Alkalay, Head of IP, AMDOCS

Stephen (Steve) McDonald, IP Portfolio Manager for Graphene & 2D Materials


Moderator:  Nels T. Lippert, Tarter Krinsky

Friend or Foe: Licensing vs. Litigation  

The Ups and Downs of Licensing your IP vs. Litigating 


Michael Fink, Greenblum Bernstein

Nicole Morris, Professor, Emory University School of Law (former Managing Patent Counsel The Coca-Cola Company)

Dr. Yoav Oestreicher, Meitar

Moderator:  Barry Schindler, Greenberg Traurig  

IP Protective Measures: Offensive v. Defensive Strategies

How do you craft your portfolio in order to best support your strategy? What is the best way for your company to slow down your competitors and increase their cost and uncertainty?


Tal Band, S. Horowitz & Co.


Moderator: Barry Schindler, Greenberg Traurig

15:30 - 16:15

Trade Secrets: How to Implement an Effective TS Policy in an Israeli Company


Nicole Morris, Former Patent Counsel Coca Cola, Prof. Emory University School of Law


Yael Riemer, Fischer Behar Chen Well Orion & Co.


John Halan, Brooks Kushman


Moderator: Adam Samansky, Mintz Levin

16:15 - 17:00

Accelerations, Examinations US and EU Tips and Tricks. Different options for accelerating examination from leading jurisdictions/Measures (HPP, US and EP,CN), the procedural, legal, financial and strategic issues involved.


Gall C. Gotfried, Haley Guiliano LLP


Erin Bowles, Brooks Kushman 

Moderator: Ori Buberman, Head of Intellectual Property, Mobileye

Intellectual Property in Health Tech: What are the Musts 


Daniella Atzmony, Syqe Medical


Erich Andersen, VP IP, Microsoft

Barry Schindler, Greenberg Traurig

Bethany Hills, Mintz Levin

Gerson Panitch, Finnegan


Moderator: Levi Shapiro, MHealth

08:15 – 09:00

Registration and Buffet Breakfast

09:00 – 10:00


Kimberly Lindy, Intellectual Property Resources


Opening Remarks

Daniella Atzmony, Chairperson of the Israel IP Managers and Counsel Forum and CIPO and General Counsel, Syqe Medical


Introduction to Keynote 

Yoav Alkalay Co Chair BPIP Conference, Head of IP, AMDOCS

Keynote Address

Erich Andersen, VP and Chief IP Counsel of Microsoft, speaking on:

Intellectual Property Dimensions of Artificial Intelligence and the Future of IP


10:00 – 10:45

Roundtable Discussion on Subject Matter Eligibility and Obviousness in the United States and Around the World

 Moderator: Micaela Modiano, Senior Partner, Modiano and Partners, Europe


  • Lou Sorell, Patent Counsel, Google

  • Adam Samansky, Co Chair 6th Annual BPIP, Member Mintz Levin, US

  • Nicole Morris,  Professor, Emory University School of Law (former Managing Patent Counsel The Coca-Cola Company)

  • Stephen (Steve) McDonald, IP Portfolio Manager for Graphene & 2D Materials


Panel to discuss requirements, policy issues and strategy in view of different standards around the globe affecting tech and life sciences.


10:45 - 11:15

Networking Break

11:15 - 12:00   

A Mock PTAB Hearing: Patent Validity on Trial 

Subject Matter: A Converging MedTech Technology  

Moderators:  Barry Schindler, Shareholder Greenberg Traurig; Michael Faibisch, Senior IP Counsel, Marvel Israel.

Counsel: Adam Samansky, Co Chair 6th Annual BPIP, Member Mintz Levin

Counsel:  Jeffrey Berkowitz, Partner, Finnegan

Judge: Former PTAB Judge Trenton Ward, Partner, Finnegan


This session will present a mock PTAB hearing on obviousness and subject matter eligibility, as would be seen in a petition for post grant review under 35 U.S.C. § 101 and § 103. Argument will be split between subject matter eligibility and obviousness, prima facie, and whether claim construction is necessary to decide the validity issues.

12:00 - 12:30

Special Guest 

Dr. Nathalie Bloch, Director of the Innovation Center Sheba Medical Center, Tel Hashomer

speaking on: Innovation Trends in Medical Health 2018

12:30 - 13:45   


Luncheon Seminar

Patent Databases and Analytics: What You Always Wanted to know about but never dared to ask.

Essential and sometimes surprising information for a better understanding and more efficient use

Daniel Ovadya, Questel

(Limited seats. You must sign up when registering)






14:30 - 15:15

Bringing Down the Costs: IP Budget Planning. Tips and Tricks

How to negotiate with your patent attorney; Analyzing your patent portfolio.


Michael A. Cantor, Cantor Colburn

William Kezer, Mintz Levin

Noam Mushkin, until recently VP IP Perrigo 


Moderator: Micaela Modiano, Modiano and Partners